273 related articles for article (PubMed ID: 9387909)
21. [Role of the class II tumor suppressor gene maspin in thyroid carcinogenesis].
Boltze C; Hoang-Vu C; Schneider-Stock R; Lehnert H; Roessner A
Verh Dtsch Ges Pathol; 2004; 88():237-45. PubMed ID: 16892558
[TBL] [Abstract][Full Text] [Related]
22. Nakahara memorial lecture. Hereditary cancer, oncogenes, and anti-oncogenes.
Knudson AG
Princess Takamatsu Symp; 1989; 20():15-29. PubMed ID: 2577335
[TBL] [Abstract][Full Text] [Related]
23. [Better understanding of the biology of cancer cells].
Klein G
Ugeskr Laeger; 2000 Sep; 162(39):5199-204. PubMed ID: 11043045
[TBL] [Abstract][Full Text] [Related]
24. [Better understanding of the biology of cancer cells].
Klein G
Lakartidningen; 2000 Jul; 97(28-29):3260-4. PubMed ID: 10997012
[TBL] [Abstract][Full Text] [Related]
25. Heterozygous Aprt mouse model: detection and study of a broad range of autosomal somatic mutations in vivo.
Vrieling H; Wijnhoven S; van Sloun P; Kool H; Giphart-Gassler M; van Zeeland A
Environ Mol Mutagen; 1999; 34(2-3):84-9. PubMed ID: 10529730
[TBL] [Abstract][Full Text] [Related]
26. [Origin and progression of thyroid epithelial tumors: molecular and cellular mechanisms].
Gire V; Wynford-Thomas D
Arch Anat Cytol Pathol; 1998; 46(1-2):11-8. PubMed ID: 9754356
[TBL] [Abstract][Full Text] [Related]
27. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2005 Feb; 24(8):1455-60. PubMed ID: 15608681
[TBL] [Abstract][Full Text] [Related]
28. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
29. Gene rearrangements in radiation-induced thyroid carcinogenesis.
Rabes HM
Med Pediatr Oncol; 2001 May; 36(5):574-82. PubMed ID: 11340615
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
[TBL] [Abstract][Full Text] [Related]
31. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
[TBL] [Abstract][Full Text] [Related]
32. Gene expression, cellular diversification and tumor progression to the metastatic phenotype.
Nicolson GL
Bioessays; 1991 Jul; 13(7):337-42. PubMed ID: 1759975
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
34. [Neurologic diseases due to alterations in oncogenes and tumor suppressing genes].
Bello MJ; Rey JA
Neurologia; 1995 Dec; 10 Suppl 1():20-31. PubMed ID: 8838556
[TBL] [Abstract][Full Text] [Related]
35. [Genetics of renal tumors].
Oláh E; Jakab Z; Balogh E
Orv Hetil; 2001 Jul; 142(26):1367-73. PubMed ID: 11478032
[TBL] [Abstract][Full Text] [Related]
36. [Identification of oncogenes and anti-oncogenes].
Thomas G
Pathol Biol (Paris); 1995 Mar; 43(3):143-9. PubMed ID: 7675540
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of oncogenesis.
Seemayer TA; Cavenee WK
Lab Invest; 1989 May; 60(5):585-99. PubMed ID: 2654471
[TBL] [Abstract][Full Text] [Related]
38. [Tumor suppressor genes. New perspectives for clinical investigations in cancer].
Paván J; Gualandi F; Rimessi P; Corallini A; Barbanti-Brodano G
Medicina (B Aires); 1994; 54(2):163-8. PubMed ID: 7997135
[TBL] [Abstract][Full Text] [Related]
39. Genetic regulation of metastatic progression.
Wright JA; Egan SE; Greenberg AH
Anticancer Res; 1990; 10(5A):1247-55. PubMed ID: 2241100
[TBL] [Abstract][Full Text] [Related]
40. Somatic events unmask recessive cancer genes to initiate malignancy.
Gallie BL; Worton RG
J Cell Biochem; 1986; 32(3):215-22. PubMed ID: 3023409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
